F P Rugman

505 total citations
12 papers, 367 citations indexed

About

F P Rugman is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, F P Rugman has authored 12 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Otorhinolaryngology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in F P Rugman's work include Head and Neck Cancer Studies (4 papers), Venomous Animal Envenomation and Studies (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). F P Rugman is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Venomous Animal Envenomation and Studies (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). F P Rugman collaborates with scholars based in United Kingdom, Australia and Brazil. F P Rugman's co-authors include C. R. M. Hay, R.D.G. Theakston, M. McCormick, Aura S. Kamiguti, P. M. Stell, Randall P. Morton, J. A. Wilson, A. Veevers, Peter Stoney and R A Hutton and has published in prestigious journals such as Journal of Clinical Pathology, Thrombosis and Haemostasis and Toxicon.

In The Last Decade

F P Rugman

12 papers receiving 356 citations

Peers

F P Rugman
Y Tomita Japan
Linda Simmons-Arnold United States
Mark A. Merkley United States
P. Ide Belgium
Ritu Sarin United States
M.J. van Gent Netherlands
Y Tomita Japan
F P Rugman
Citations per year, relative to F P Rugman F P Rugman (= 1×) peers Y Tomita

Countries citing papers authored by F P Rugman

Since Specialization
Citations

This map shows the geographic impact of F P Rugman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F P Rugman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F P Rugman more than expected).

Fields of papers citing papers by F P Rugman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F P Rugman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F P Rugman. The network helps show where F P Rugman may publish in the future.

Co-authorship network of co-authors of F P Rugman

This figure shows the co-authorship network connecting the top 25 collaborators of F P Rugman. A scholar is included among the top collaborators of F P Rugman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F P Rugman. F P Rugman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rugman, F P, et al.. (1994). Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors.. PubMed. 5(3). 335–40. 22 indexed citations
2.
Kamiguti, Aura S., F P Rugman, R.D.G. Theakston, et al.. (1992). The Role of Venom Haemorrhagin in Spontaneous Bleeding in Bothrops jararaca Envenoming. Thrombosis and Haemostasis. 67(4). 484–488. 39 indexed citations
3.
Kamiguti, Aura S., João Luiz Costa Cardoso, R.D.G. Theakston, et al.. (1991). Coagulopathy and haemorrhage in human victims of Bothrops jararaca envenoming in Brazil. Toxicon. 29(8). 961–972. 84 indexed citations
4.
Rugman, F P, et al.. (1991). Anticardiolipin antibodies in leptospirosis.. Journal of Clinical Pathology. 44(6). 517–519. 17 indexed citations
5.
Rugman, F P, et al.. (1990). Aplastic anaemia associated with organochlorine pesticide: case reports and review of evidence.. Journal of Clinical Pathology. 43(2). 98–101. 33 indexed citations
6.
Rugman, F P, et al.. (1990). A bite by a carpet viper (Echis carinatus) in a research institute. Clinical & Laboratory Haematology. 12(2). 221–228. 4 indexed citations
7.
Davenport, Andrew, et al.. (1989). Is thrombocytopenia seen in patients with leptospirosis immunologically mediated?. Journal of Clinical Pathology. 42(4). 439–440. 28 indexed citations
8.
Jb, Campbell, et al.. (1987). A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer.. PubMed. 103(5-6). 519–28. 18 indexed citations
9.
Rugman, F P, et al.. (1987). [Cisplatin and bleomycin in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck. A randomized facultative Phase III controlled study].. PubMed. 81. 141–50. 1 indexed citations
10.
Nash, J R, et al.. (1987). Non-Hodgkin's lymphoma of the head and neck: prognostic factors. Clinical Otolaryngology. 12(3). 203–210. 6 indexed citations
11.
Campbell, Jeffrey B., Timothy R. Helliwell, M. McCormick, et al.. (1987). Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinum. Clinical Otolaryngology. 12(3). 167–176. 4 indexed citations
12.
Morton, Randall P., F P Rugman, Peter Stoney, et al.. (1985). Cisplatinum and Bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. Cancer Chemotherapy and Pharmacology. 15(3). 283–9. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026